Literature DB >> 17195717

Treatment of Dientamoeba fragilis infection with paromomycin.

Olivier Vandenberg1, Hichem Souayah, Françoise Mouchet, Anne Dediste, Tom van Gool.   

Abstract

Treatment with paromomycin (25-35 mg/kg/d for 7 days) was evaluated prospectively in 15 children with Dientamoeba fragilis infection after 1-month follow-up. At the end of the study, parasitologic effectiveness and clinical improvement were observed in 12/15 (80%) and 13/15 (87%) patients, respectively. Paromomycin appears to be an effective drug for treatment of D. fragilis infection in children.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17195717     DOI： 10.1097/01.inf.0000247139.89191.91

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


  13 in total

1.  Detection and transmission of Dientamoeba fragilis from environmental and household samples.

Authors:  Damien Stark; Tamalee Roberts; Deborah Marriott; John Harkness; John T Ellis
Journal:  Am J Trop Med Hyg       Date:  2012-02       Impact factor: 2.345

2.  A review of the clinical presentation of dientamoebiasis.

Authors:  Damien Stark; Joel Barratt; Tamalee Roberts; Deborah Marriott; John Harkness; John Ellis
Journal:  Am J Trop Med Hyg       Date:  2010-04       Impact factor: 2.345

Review 3.  Dientamoeba fragilis, the Neglected Trichomonad of the Human Bowel.

Authors:  Damien Stark; Joel Barratt; Douglas Chan; John T Ellis
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

4.  Comparison of microscopy, two xenic culture techniques, conventional and real-time PCR for the detection of Dientamoeba fragilis in clinical stool samples.

Authors:  D Stark; J Barratt; T Roberts; D Marriott; J Harkness; J Ellis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-02-14       Impact factor: 3.267

Review 5.  Enteric protozoa in the developed world: a public health perspective.

Authors:  Stephanie M Fletcher; Damien Stark; John Harkness; John Ellis
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

6.  Treatment of Dientamoeba fragilis in patients with irritable bowel syndrome.

Authors:  Anne Line Engsbro; C Rune Stensvold; Henrik V Nielsen; Peter Bytzer
Journal:  Am J Trop Med Hyg       Date:  2012-10-22       Impact factor: 2.345

7.  Dientamoeba fragilis in Denmark: epidemiological experience derived from four years of routine real-time PCR.

Authors:  D Röser; J Simonsen; H V Nielsen; C R Stensvold; K Mølbak
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-04-24       Impact factor: 3.267

8.  Is paromomycin the drug of choice for eradication of Dientamoeba fragilis in adults?

Authors:  Jaap J van Hellemond; Nicky Molhoek; Rob Koelewijn; Pieter J Wismans; Perry J J van Genderen
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-04-14       Impact factor: 4.077

Review 9.  Current treatment options for Dientamoeba fragilis infections.

Authors:  Noriyuki Nagata; Deborah Marriott; John Harkness; John T Ellis; Damien Stark
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-09-03       Impact factor: 4.077

10.  Repeated Dientamoeba fragilis infections: a case report of two families from Sydney, Australia.

Authors:  Damien Stark; Joel Barratt; John Ellis; John Harkness; Deborah Marriott
Journal:  Infect Dis Rep       Date:  2009-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.